Company Accounts and Tax Online 10149341 Board of Directors 1.5.24 30.4.25 30.4.25 No description of principal activity false iso4217:GBP xbrli:pure 10149341 2023-05-01 2024-04-30 10149341 2025-04-30 10149341 2024-05-01 2025-04-30 10149341 2024-04-30 10149341 countries:EnglandWales 2024-05-01 2025-04-30 10149341 curr:PoundSterling 2024-05-01 2025-04-30 10149341 uk-bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 10149341 uk-bus:Micro-entities 2024-05-01 2025-04-30 10149341 uk-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 10149341 uk-bus:FullAccounts 2024-05-01 2025-04-30 10149341 uk-bus:RegisteredOffice 2024-05-01 2025-04-30 10149341 uk-bus:Director1 2024-05-01 2025-04-30 10149341 uk-bus:Director1 2024-05-01 10149341 uk-bus:Director1 2025-04-30 10149341 core:AfterOneYear 2025-04-30 10149341 core:AfterOneYear 2024-04-30 10149341 core:WithinOneYear 2025-04-30 10149341 core:WithinOneYear 2024-04-30 10149341 core:WithinOneYear 2024-05-01 2025-04-30 10149341 core:AfterOneYear 2025-04-30 10149341 core:AfterOneYear 2024-04-30 10149341 core:AfterOneYear 2024-05-01 2025-04-30 10149341 core:ShareCapital 2025-04-30 10149341 core:ShareCapital 2024-04-30 10149341 core:RevaluationReserve 2025-04-30 10149341 core:RevaluationReserve 2024-04-30 10149341 core:RetainedEarningsAccumulatedLosses 2025-04-30 10149341 core:RetainedEarningsAccumulatedLosses 2024-04-30 10149341 1 2024-05-01 2025-04-30

# IMMUNOCONSULTING LIMITED

## Company Registration Number:
10149341 (England and Wales)

## Unaudited micro entity accounts for the year ended 30 April 2025

## Period of accounts

## Start date: 01 May 2024

## End date: 30 April 2025

# IMMUNOCONSULTING LIMITED

## Contents of the Financial Statements

for the Period Ended 30 April 2025

Company Information - 3 |
Balance sheet - 4 |
Footnotes to the Balance Sheet - 6 |

# IMMUNOCONSULTING LIMITED

## Company Information

for the Period Ended 30 April 2025

Registered office: |  | 6 Ellis Close Quorn Loughborough Leicestershire GBR LE12 8SH
Company Registration Number: |  | 10149341 (England and Wales)

# IMMUNOCONSULTING LIMITED

## Balance sheet

As at 30 April 2025

| 2025 £ | 2024 £
--- | --- | ---
Called up share capital not paid: | 0 | 0
Fixed Assets: | 607 | 880
Current assets: | 880,266 | 818,511
Prepayments and accrued income: | 260 | 263
Creditors: amounts falling due within one year: | ( 64,714 ) | ( 93,750 )
Net current assets (liabilities): | 815,812 | 725,024
Total assets less current liabilities: | 816,419 | 725,904
Creditors: amounts falling due after more than one year: | ( 0 ) | ( 0 )
Provision for liabilities: | ( 0 ) | ( 0 )
Accruals and deferred income: | ( 0 ) | ( 0 )
Total net assets (liabilities): | 816,419 | 725,904
Capital and reserves: | 816,419 | 725,904

# IMMUNOCONSULTING LIMITED

## Balance sheet continued

For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 26 May 2025
And Signed On Behalf Of The Board By:

Name: Andrew James Leishman
Status: Director

The notes form part of these financial statements

# IMMUNOCONSULTING LIMITED

## Footnotes to the Financial Statements

for the Period Ended 30 April 2025

- ## 1. Employee Information

  Average number of employees: 1

# IMMUNOCONSULTING LIMITED

## Footnotes to the Financial Statements

for the Period Ended 30 April 2025

- ## 2. Off balance sheet disclosure

  No